Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Mitochondrial energy metabolism and redox systems are the fundamental biochemical frameworks responsible for generating adenosine triphosphate (ATP) and maintaining cellular reduction-oxidation (redox) balance (Sies et al., 2017). These systems primarily operate through the tricarboxylic acid (TCA) cycle and the oxidative phosphorylation (OXPHOS) pathway, where electron transport chain (ETC) complexes create a proton gradient to drive ATP synthesis (Gorman et al., 2016). Beyond energy production, these systems are critical for regulating reactive oxygen species (ROS) levels, calcium signaling, and the initiation of apoptosis (Weinberg & Chandel, 2015). Dysregulation of mitochondrial bioenergetics is a key driver in various pathologies, including neurodegenerative diseases like Parkinson's and Alzheimer's, as well as metabolic disorders and cancer (Suomalainen et al., 2011). Pharmacological targeting of these systems involves modulating specific ETC complexes, utilizing mitochondrial-targeted antioxidants, or employing metabolic uncouplers to alter energy expenditure (Bridges et al., 2014). Because mitochondrial function is essential for nearly all eukaryotic cells, therapeutic interventions must be precisely calibrated to avoid systemic toxicity and metabolic collapse.
Modulation of electron transport chain (ETC) complexes, uncoupling of oxidative phosphorylation, and scavenging of reactive oxygen species (ROS) to restore metabolic homeostasis or induce apoptosis (Bridges et al., 2014; Sies et al., 2017).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial energy metabolism and redox systems.